1. Home
  2. WST vs ROL Comparison

WST vs ROL Comparison

Compare WST & ROL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • ROL
  • Stock Information
  • Founded
  • WST 1923
  • ROL 1948
  • Country
  • WST United States
  • ROL United States
  • Employees
  • WST N/A
  • ROL N/A
  • Industry
  • WST Medical/Dental Instruments
  • ROL Diversified Commercial Services
  • Sector
  • WST Health Care
  • ROL Finance
  • Exchange
  • WST Nasdaq
  • ROL Nasdaq
  • Market Cap
  • WST 15.6B
  • ROL 27.6B
  • IPO Year
  • WST N/A
  • ROL N/A
  • Fundamental
  • Price
  • WST $220.98
  • ROL $55.04
  • Analyst Decision
  • WST Buy
  • ROL Buy
  • Analyst Count
  • WST 7
  • ROL 8
  • Target Price
  • WST $331.67
  • ROL $59.50
  • AVG Volume (30 Days)
  • WST 615.3K
  • ROL 1.6M
  • Earning Date
  • WST 07-24-2025
  • ROL 07-23-2025
  • Dividend Yield
  • WST 0.38%
  • ROL 1.20%
  • EPS Growth
  • WST N/A
  • ROL 9.41
  • EPS
  • WST 6.37
  • ROL 0.99
  • Revenue
  • WST $2,895,800,000.00
  • ROL $3,462,863,000.00
  • Revenue This Year
  • WST $3.38
  • ROL $11.84
  • Revenue Next Year
  • WST $5.82
  • ROL $8.58
  • P/E Ratio
  • WST $34.74
  • ROL $56.57
  • Revenue Growth
  • WST N/A
  • ROL 9.46
  • 52 Week Low
  • WST $187.43
  • ROL $45.34
  • 52 Week High
  • WST $352.33
  • ROL $58.65
  • Technical
  • Relative Strength Index (RSI)
  • WST 49.84
  • ROL 40.98
  • Support Level
  • WST $219.60
  • ROL $54.85
  • Resistance Level
  • WST $233.84
  • ROL $55.91
  • Average True Range (ATR)
  • WST 5.32
  • ROL 0.97
  • MACD
  • WST 0.04
  • ROL -0.12
  • Stochastic Oscillator
  • WST 29.22
  • ROL 7.10

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About ROL Rollins Inc.

Rollins is a global leader in route-based pest control services, with operations primarily in the United States, as well as in North, Central, and South America, Europe, the Middle East, Africa, and Australia. Its portfolio of pest-control brands includes the prominent Orkin brand, a market leader in the US, which boasts near national coverage, and in Canada. Residential pest and termite prevention dominates the services provided by Rollins, owing to the group's ongoing focus on the US and Canadian markets.

Share on Social Networks: